PharmaTher Holdings Ltd. (CSE:PHRM)
Canada
· Delayed Price · Currency is CAD 0.0700
-0.0150 (-17.65%)
Mar 9, 2026, 1:42 PM EST
PharmaTher Holdings Balance Sheet
Financials in millions CAD. Fiscal year is June - May.
Millions CAD. Fiscal year is Jun - May.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 |
|---|---|---|---|---|---|---|---|
Period Ending | Nov '25 Nov 30, 2025 | May '25 May 31, 2025 | May '24 May 31, 2024 | May '23 May 31, 2023 | May '22 May 31, 2022 | May '21 May 31, 2021 | 2020 |
| Cash & Equivalents | 0.7 | 0.92 | 2.13 | 5.92 | 9.15 | 2.78 | Upgrade
|
| Short-Term Investments | 0.07 | 0.2 | 0.17 | 0.33 | 2.97 | 3.1 | Upgrade
|
| Cash & Short-Term Investments | 0.77 | 1.12 | 2.3 | 6.25 | 12.12 | 5.88 | Upgrade
|
| Cash Growth | -50.38% | -51.16% | -63.22% | -48.41% | 106.22% | 1413.48% | Upgrade
|
| Other Receivables | 0.02 | 0.02 | 0.02 | 0.06 | 0.03 | 0.03 | Upgrade
|
| Receivables | 0.02 | 0.02 | 0.02 | 0.06 | 0.03 | 0.03 | Upgrade
|
| Prepaid Expenses | - | - | 0.02 | - | 0.01 | 0.03 | Upgrade
|
| Total Current Assets | 0.79 | 1.14 | 2.34 | 6.31 | 12.16 | 5.94 | Upgrade
|
| Property, Plant & Equipment | - | - | - | 0 | 0 | 0 | Upgrade
|
| Long-Term Investments | 0.19 | 0.2 | 0.25 | - | - | - | Upgrade
|
| Total Assets | 0.98 | 1.34 | 2.59 | 6.31 | 12.16 | 5.94 | Upgrade
|
| Accounts Payable | 0.44 | 0.36 | 0.24 | 0.88 | 0.32 | 0.13 | Upgrade
|
| Accrued Expenses | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Current Income Taxes Payable | - | - | - | - | - | 0.04 | Upgrade
|
| Total Current Liabilities | 0.44 | 0.37 | 0.25 | 0.89 | 0.33 | 0.18 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | - | - | - | - | 0.19 | Upgrade
|
| Total Liabilities | 0.44 | 0.37 | 0.25 | 0.89 | 0.33 | 0.36 | Upgrade
|
| Common Stock | 8.95 | 8.5 | 8.5 | 8.44 | 8.44 | 2.37 | Upgrade
|
| Additional Paid-In Capital | 0.46 | 0.71 | 0.55 | 0.65 | 0.65 | 0.34 | Upgrade
|
| Retained Earnings | -12.99 | -12.35 | -10.83 | -7.78 | -1.37 | 2.64 | Upgrade
|
| Comprehensive Income & Other | 4.11 | 4.11 | 4.11 | 4.11 | 4.11 | 0.23 | Upgrade
|
| Shareholders' Equity | 0.54 | 0.97 | 2.34 | 5.42 | 11.83 | 5.58 | Upgrade
|
| Total Liabilities & Equity | 0.98 | 1.34 | 2.59 | 6.31 | 12.16 | 5.94 | Upgrade
|
| Net Cash (Debt) | 0.77 | 1.12 | 2.3 | 6.25 | 12.12 | 5.88 | Upgrade
|
| Net Cash Growth | -50.38% | -51.16% | -63.22% | -48.41% | 106.22% | 1413.48% | Upgrade
|
| Net Cash Per Share | 0.01 | 0.01 | 0.03 | 0.07 | 0.15 | 0.08 | Upgrade
|
| Filing Date Shares Outstanding | 91.02 | 91.02 | 88.52 | 88.17 | 88.17 | 69.73 | Upgrade
|
| Total Common Shares Outstanding | 91.02 | 91.02 | 88.52 | 88.17 | 88.17 | 67.73 | Upgrade
|
| Working Capital | 0.34 | 0.77 | 2.09 | 5.42 | 11.83 | 5.76 | Upgrade
|
| Book Value Per Share | 0.01 | 0.01 | 0.03 | 0.06 | 0.13 | 0.08 | Upgrade
|
| Tangible Book Value | 0.54 | 0.97 | 2.34 | 5.42 | 11.83 | 5.58 | Upgrade
|
| Tangible Book Value Per Share | 0.01 | 0.01 | 0.03 | 0.06 | 0.13 | 0.08 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.